Dopamine D3 Receptors Inhibit Hippocampal Gamma Oscillations by Disturbing CA3 Pyramidal Cell Firing Synchrony

Frontiers in Pharmacology
Clément E LemercierZoltan Gerevich

Abstract

Cortical gamma oscillations are associated with cognitive processes and are altered in several neuropsychiatric conditions such as schizophrenia and Alzheimer's disease. Since dopamine D3 receptors are possible targets in treatment of these conditions, it is of great importance to understand their role in modulation of gamma oscillations. The effect of D3 receptors on gamma oscillations and the underlying cellular mechanisms were investigated by extracellular local field potential and simultaneous intracellular sharp micro-electrode recordings in the CA3 region of the hippocampus in vitro. D3 receptors decreased the power and broadened the bandwidth of gamma oscillations induced by acetylcholine or kainate. Blockade of the D3 receptors resulted in faster synchronization of the oscillations, suggesting that endogenous dopamine in the hippocampus slows down the dynamics of gamma oscillations by activation of D3 receptors. Investigating the underlying cellular mechanisms for these effects showed that D3 receptor activation decreased the rate of action potentials (APs) during gamma oscillations and reduced the precision of the AP phase coupling to the gamma cycle in CA3 pyramidal cells. The results may offer an explanation how sele...Continue Reading

References

Oct 1, 1995·Brain Research. Molecular Brain Research·N M RichtandR Kuczenski
Feb 11, 1998·Physiological Reviews·C MissaleM G Caron
Jun 17, 1999·Pharmacology, Biochemistry, and Behavior·A G SmithB Costall
Nov 24, 1999·Archives of General Psychiatry·J S KwonR W McCarley
Feb 28, 2003·Psychiatric Genetics·Erik G JönssonGöran C Sedvall
Dec 19, 2003·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·György SzekeresZoltán Janka
Oct 29, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·André FisahnChris J McBain
Dec 25, 2004·Psychopharmacology·Judit LaszyIstván Gyertyán
Dec 24, 2005·Nature·Thilo WomelsdorfRobert Desimone
Jan 22, 2008·Journal of Clinical Psychopharmacology·Ajna HamidovicHarriet de Wit
Jul 25, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Andres Buehlmann, Gustavo Deco
Sep 17, 2008·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Florence Loiseau, Mark J Millan
Feb 10, 2009·The European Journal of Neuroscience·Norbert HájosOle Paulsen
Jan 21, 2010·Nature Reviews. Neuroscience·Peter J Uhlhaas, Wolf Singer
Mar 23, 2010·Schizophrenia Research·Seung-Hwan LeeChang-Hwan Im
Aug 18, 2010·International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology·C MulertKevin M Spencer
Sep 22, 2010·Progress in Medicinal Chemistry·Gregor J MacDonald, José Manuel Bartolomé
Nov 12, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Attila I GulyásNorbert Hájos
Dec 24, 2010·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Ragy R GirgisMark Slifstein
Jun 11, 2011·European Journal of Pharmacology·Yoshihiro TadoriTetsuro Kikuchi
Oct 28, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·David J G WatsonKevin C F Fone
Jul 24, 2012·Proceedings of the National Academy of Sciences of the United States of America·Richard H AnderssonAndres Buonanno
Nov 7, 2012·Naunyn-Schmiedeberg's Archives of Pharmacology·Gerhard GrossKarla U Drescher
Mar 26, 2013·Neuron·John E Lisman, Ole Jensen
Jun 25, 2013·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Shinichiro NakajimaAriel Graff-Guerrero
Nov 8, 2013·Frontiers in Systems Neuroscience·Edmund T Rolls
Oct 14, 2014·The European Journal of Neuroscience·Gürsel ÇalışkanZoltan Gerevich
Oct 18, 2014·Frontiers in Human Neuroscience·Rachael D RubinNeal J Cohen

❮ Previous
Next ❯

Software Mentioned

Spike2

Related Concepts

Related Feeds

Basal Forebrain- Circuits

Basal forebrain is a region in the brain important for production of acetylcholine and is the major cholinergic output of the CNS. Discover the latest research on circuits in the basal forebrain here.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here